A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Biochaperone Combo

Injection of BioChaperone Combo

DRUG

Humalog Mix25

Injection of Humalog Mix25

DRUG

Humalog

Injection of Humalog

DRUG

Lantus

Injection of Lantus

DRUG

Placebo

Injection of saline 0.9% solution

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss